Journalist

Ryu Yuna
Ryu Yuna류윤아
ReporterFinancial Supervisory Service (FSS) & finance, capital markets, Southeast Asian affairs
Yuna Ryu covers finance, capital markets and Southeast Asian affairs.
She is drawn to the questions that numbers raise and the stories that data alone cannot answer.
Prior to journalism, she worked at Hyundai Motor Company and the Singapore Chamber of Commerce, focusing on business strategy and international affairs. She has also hosted diplomatic receptions and international conferences as an MC.

Ryu holds a master's degree in Media and Communication from Korea University, where her research focused on neuroscience-based studies of media effects. "Beyond every statistic is a human story waiting to be heard."
Busan fever sweeps Asia as Taiwanese lead new tourism boom Busan fever sweeps Asia as Taiwanese lead new tourism boom

Busan fever sweeps Asia as Taiwanese lead new tourism boom

S&P lifts Samsung outlook as AI memory boom gathers pace S&P lifts Samsung outlook as AI memory boom gathers pace

S&P lifts Samsung outlook as AI memory boom gathers pace

KOSDAQ gains new life from robotics jolt KOSDAQ gains new life from robotics jolt

KOSDAQ gains new life from robotics jolt

Seoul steps in as ETF crash takes toll on retirees and minors Seoul steps in as ETF crash takes toll on retirees and minors

Seoul steps in as ETF crash takes toll on retirees and minors

Lee orders review of leveraged chip ETFs after retail investor losses Lee orders review of leveraged chip ETFs after retail investor losses

Lee orders review of leveraged chip ETFs after retail investor losses

New AI rules take effect in South Korea New AI rules take effect in South Korea

New AI rules take effect in South Korea

Hanwha Solutions rights issue cut to $810 million after 21% discount Hanwha Solutions rights issue cut to $810 million after 21% discount

Hanwha Solutions rights issue cut to $810 million after 21% discount

Samchundang Pharm shares surge on hopes for diabetes generic Samchundang Pharm shares surge on hopes for diabetes generic

Samchundang Pharm shares surge on hopes for diabetes generic

Bio, fashion IPOs seek to inject life into subdued KOSDAQ Bio, fashion IPOs seek to inject life into subdued KOSDAQ

Bio, fashion IPOs seek to inject life into subdued KOSDAQ

Four in 10 Korean listed firms face weaker Q2 Four in 10 Korean listed firms face weaker Q2

Four in 10 Korean listed firms face weaker Q2